These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Alpha-1-antitrypsin deficiency in a Southland family. Browne RL N Z Med J; 1975 Nov; 82(551):291-3. PubMed ID: 1082114 [TBL] [Abstract][Full Text] [Related]
43. [Substitution of alpha 1-antitrypsin in patients with pulmonary emphysema and alpha 1-antitrypsin deficiency]. Schmidt EW; Rasche B; Ulmer WT Verh Dtsch Ges Inn Med; 1988; 94():6-11. PubMed ID: 3264647 [No Abstract] [Full Text] [Related]
44. Alpha 1 antitrypsin deficiency: clinical and physiological features in heterozygotes of Pi type SZ. A survey by the British Thoracic Association. Hutchison DC; Tobin MJ; Cook PJ Br J Dis Chest; 1983 Jan; 77(1):28-34. PubMed ID: 6602622 [TBL] [Abstract][Full Text] [Related]
45. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency. Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857 [TBL] [Abstract][Full Text] [Related]
46. Pulmonary function associated with the Mmalton deficient variant of alpha 1-antitrypsin. Sproule BJ; Cox DW; Hsu K; Salkie ML; Herbert FA Am Rev Respir Dis; 1983 Feb; 127(2):237-40. PubMed ID: 6600898 [TBL] [Abstract][Full Text] [Related]
47. Association of alpha 1-antitrypsin deficiency with lung and liver diseases. Resendes M West J Med; 1987 Jul; 147(1):48-53. PubMed ID: 3321708 [TBL] [Abstract][Full Text] [Related]
48. Pulmonary function in heterozygotes for alpha,-antitrypsin deficiency: a case-control study. Buist AS; Sexton GJ; Azzam AM; Adams BE Am Rev Respir Dis; 1979 Oct; 120(4):759-66. PubMed ID: 315737 [TBL] [Abstract][Full Text] [Related]
49. Biochemical reaction of alpha 1 antitrypsin during the substitution therapy of patients with homozygote PI-ZZ deficit. Gillissen A; Schmidt EW; Rasche B; Ulmer WT Klin Wochenschr; 1989 Mar; 67(6):328-35. PubMed ID: 2785232 [TBL] [Abstract][Full Text] [Related]
50. Biochemical intermediates in alpha 1-antitrypsin deficiency: residual family resemblance for total alpha 1-antitrypsin, oxidized alpha 1-antitrypsin, and immunoglobulin E after adjustment for the effect of the Pi locus. Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC Genet Epidemiol; 1990; 7(2):137-49. PubMed ID: 2338230 [TBL] [Abstract][Full Text] [Related]
51. Alpha1-antitrypsin deficiency (second of two parts). Morse JO N Engl J Med; 1978 Nov; 299(20):1099-105. PubMed ID: 360065 [No Abstract] [Full Text] [Related]
58. Changes of volume of trapped gas after bronchodilation in subjects with suspected subclinical emphysema. Christensson P; Arborelius M; Kautto-Wiberg R Respiration; 1986; 49(1):16-22. PubMed ID: 3485300 [TBL] [Abstract][Full Text] [Related]
59. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy. Cox DW; Hoeppner VH; Levison H Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700 [TBL] [Abstract][Full Text] [Related]
60. Emphysema due to alpha-antitrypsin deficiency: familial study of the YBARCELONA variant. Miravitlles M; Vilà S; Jardí R; de la Roza C; Rodríguez-Frías F; Vidal R Chest; 2003 Jul; 124(1):404-6. PubMed ID: 12853554 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]